Estrogen receptor positive cell lines MCF-7 and T47D showed about 70% inhibition of cell growth on an average while the ER-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468 showed a higher sensitivity to the combination with around ~80% inhibition (Table 1). This evidence concerns the gene ESR1 and breast carcinoma.